Shortly after Evofem picked up FDA approval for its contraceptive gel Phexxi back in 2020, the company touted the product as the "first contraceptive innovation in decades" and one that offered a new ...

The FDA has taken Evofem Biosciences to task for allegedly playing fast and loose with the facts, accusing the biotech of overstating the benefits of its contraceptive Phexxi in a digital patient ...

Evofem Biosciences, the buzzy but controversial women’s health startup that spent the past year trying to stay afloat, has finally found a buyer. The San Diego company, which makes the contraceptive ...

Evofem Biosciences targets the women’s health market with specialty products addressing sexual and reproductive conditions. It developed PHEXXI, a hormone-free prescription contraceptive vaginal gel, ...

SAN DIEGO, April 14, 2025 /PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) today announced that members of its management team will present at the upcoming Emerging Growth Conference as follows ...

After the close of Thursday's trading session, Evofem Biosciences (NASDAQ: EVFM) released its financial results for the fourth quarter and full year ending Dec. 31. Investors did not like what they ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, today announced the appointment ...

Evofem Biosciences, Inc. (“Evofem” or the “Company”) (OTCID: EVFM) today announced the launch of the Say Vagina Store, expanding its groundbreaking Say Vagina campaign aimed at normalizing accurate ...

Evofem Biosciences (NASDAQ: EVFM), a small-cap biopharmaceutical company that focuses on developing products to address women's reproductive health needs, is plunging on the stock market on Wednesday, ...